EXEL · Exelixis Inc
United States · RS rating 96 · As of 2026-10-14
| Price | 60.99 USD |
|---|---|
| 1-day change | +2.5% |
| RS rating (overall / 1M / 3M / 12M) | 96 / 91 / 85 / 91 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 54 / 59 / 65 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +27.5% |
| Sales growth Q/Q | +0.1% |
| Distance from 52-week high | +0.0% |
| Market cap (USD) | $11.7B |